Skip to content
Screener

Cytek Biosciences, Inc. CTKB Service — Total Revenue

Similar metrics at other companies

Evolv Technologies Holdings, Inc. logo
EVLVService revenue — Total Revenue
$78.37M+16.6%
Evolv Technologies Holdings, Inc. logo
EVLVProduct revenue — Total Revenue
$7.26M+39.8%
Evolv Technologies Holdings, Inc. logo
EVLVSubscription revenue — Total Revenue
$225.99M+11.7%
Evolv Technologies Holdings, Inc. logo
EVLVLicense fee and other revenue — Total Revenue
$987K+34.3%
MML
MMLPService revenues — Revenue, remaining performance obligation
$71.23M+14.6%
Rapid7 logo
RPDProfessional services — Total
$13.09M

Other financials

Income statement

See full
Revenue$48.1M+5.6%
Gross profit$28.3M+18.7%
Operating income-$11.4M-7.3%
Net income-$12.2M-118%
EPS (diluted)-$0.09-125%

Balance sheet

See full
Cash & equivalents$73.8M-2.2%
Total debt$17.0M-6.6%
Total equity$322.0M-14.7%
Total assets$446.9M-9.4%

Cash flow

See full
Operating cash flow-$2.7M-2,089%
CapEx$2.2M+40.5%
Free cash flow-$849.0K+42.2%

Valuation

See full
Market cap$545.93M+25.6%
Enterprise value$489.11M+29.2%
P/S2.6×+0.4×

Profitability

See full
Gross margin53.2%-1.2pp
Operating margin-21.6%
Net margin-39%
FCF margin-5.8%-11.4pp

Returns & leverage

See full
Return on equity-23%
Debt / equity0.1×0.0×
Current ratio4.5×-0.7×

Where this comes from

Reported directly by Cytek Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueRemainingPerformanceObligation.

The source filing: Cytek Biosciences, Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 5:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-053496
Line itemLess than 1 yearGreater than 1 yearTotal
Product revenue$962$962
Service revenue28,24418,05846,302
Total revenue$29,206$18,058$47,264

Item 1. Consolidated Financial Statements (Unaudited)

FAQ

What is Cytek Biosciences, Inc.'s service — total revenue?
Cytek Biosciences, Inc. (CTKB) reported service — total revenue of $46.3M in Q2 2026.
How has Cytek Biosciences, Inc.'s service — total revenue changed year-over-year?
Cytek Biosciences, Inc.'s service — total revenue increased by 5.2% year-over-year, from $44.02M to $46.3M.
What is the long-term trend for Cytek Biosciences, Inc.'s service — total revenue?
Over 3 years (2022 to 2025), Cytek Biosciences, Inc.'s service — total revenue has grown at a 29.0% compound annual growth rate (CAGR), from $81.21M to $174.49M.
What does service — total revenue mean?
This metric measures the gross revenue recognized from all service-related offerings provided to customers. It serves as a key indicator of the scale and reach of the company's post-sale support infrastructure. By tracking this figure, investors can evaluate the company's success in capturing value beyond the initial sale of hardware through ongoing service and maintenance engagements.

Ask your AI about Cytek Biosciences, Inc.'s service — total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude